-
141
A Case of Definitive Therapy for Localised Prostate Cancer: Report of a Urological Nightmare
Published 2012-01-01Get full text
Article -
142
The burden of prostate cancer in the North Africa and Middle East Region from 1990 to 2021
Published 2025-01-01Subjects: “…Prostate Cancer…”
Get full text
Article -
143
Clinical observations of patients with metastatic castration-resistant prostate cancer living in the Tambov region
Published 2023-09-01Subjects: “…metastatic castration-resistant prostate cancer…”
Get full text
Article -
144
Cosmetic Appeal, HRQoL, and Effectiveness of Simple and Pseudotesticular Techniques of Orchidectomy in Prostate Cancer
Published 2021-01-01“…Prostate Cancer…”
Get full text
Article -
145
Environment as a Potential Key Determinant of the Continued Increase of Prostate Cancer Incidence in Martinique
Published 2011-01-01“…Prostate Cancer…”
Get full text
Article -
146
The factors impacting on Gleason score upgrading in prostate cancer with initial low Gleason scores
Published 2025-02-01Subjects: Get full text
Article -
147
The Anti-proliferative Effect of a Novel Glutaminase Inhibitor IN-3 on Prostate Cancer Cells
Published 2024-09-01Subjects: “…prostate cancer…”
Get full text
Article -
148
High-Intensity Focused Ultrasound for Prostate Cancer: Long-Term Followup and Complications Rate
Published 2012-01-01“…As it is well known, High Intensity Focused Ultrasound (HIFU) is a minimally invasive procedure for prostate cancer. Many investigators reported their series of patients, demonstrating the effectiveness of the treatment. …”
Get full text
Article -
149
Generation of Whole-Genome Sequencing Data for Comparing Primary and Castration-Resistant Prostate Cancer
Published 2018-09-01Subjects: “…castration-resistant prostate cancer…”
Get full text
Article -
150
Analysis of the predictive value of the prostate-specific antigen-to-neutrophil ratio for the diagnosis of prostate cancer
Published 2025-01-01Subjects: “…Prostate cancer…”
Get full text
Article -
151
Magnetic Resonance Image-Guided Biopsies with a High Detection Rate of Prostate Cancer
Published 2012-01-01“…Ninety-six men with suspected prostate cancer underwent MRI-guided prostate biopsies under real-time imaging control in supine position. …”
Get full text
Article -
152
Circulating miRNAs as Biomarkers for Prostate Cancer Diagnosis in Subjects with Benign Prostatic Hyperplasia
Published 2020-01-01“…Identifying microRNAs (miRNAs) in subjects’ blood with various malignancies means that they can serve as novel biomarkers for prostate cancer (PCa) diagnosis. This study analyzed serum-circulating miRNAs as a noninvasive biomarker in subjects with PCa and subjects with benign prostatic hyperplasia (BPH). …”
Get full text
Article -
153
Prostate Cancer Detection from MRI Using Efficient Feature Extraction with Transfer Learning
Published 2024-01-01“…Prostate Cancer…”
Get full text
Article -
154
Combination Immunotherapy with 4-1BBL and CTLA-4 Blockade for the Treatment of Prostate Cancer
Published 2012-01-01“…These results suggest that combining activation of 4-1BB and blockade of CTLA-4 may offer a new strategy for prostate cancer immunotherapy.…”
Get full text
Article -
155
Real-World Treatment Patterns in Men with Castration- Resistant Prostate Cancer Receiving Docetaxel
Published 2015-01-01“…**Background:** Docetaxel has been a standard of care for castration-resistant prostate cancer (CRPC) in the United States since 2004, yet little has been reported on its patterns of use in routine practice. …”
Get full text
Article -
156
AI-based prediction of androgen receptor expression and its prognostic significance in prostate cancer
Published 2025-02-01“…Abstract Biochemical recurrence (BCR) of prostate cancer (PCa) negatively impacts patients’ post-surgery quality of life, and the traditional predictive models have shown limited accuracy. …”
Get full text
Article -
157
Transurethral Water Vapor Ablation: Potential for a Novel Prostate Cancer Management Strategy
Published 2025-02-01“…It is possible to successfully retreat residual disease or new lesions identified on surveillance with only transient mild to moderate adverse events and acceptable oncologic outcomes offering a new management strategy for localized prostate cancer.Plain Language Summary: Treatment decisions for men with localized prostate cancer (PCa) are determined with consideration of multiple factors including, disease risk, co-morbidities, estimated life-expectancy and each patient’s preferences. …”
Get full text
Article -
158
Mesenchymal stromal cell exosomes for drug delivery of prostate cancer treatments: a review
Published 2025-01-01“…Abstract Interest in prostate cancer as a research topic has gradually increased. …”
Get full text
Article -
159
Long-Term Survival and PSA Control with Radiation and Immunotherapy for Node Positive Prostate Cancer
Published 2009-01-01“…We describe a patient with node positive prostate cancer treated with radiation, androgen deprivation, and immunotherapy with long-term overall survival and PSA control. …”
Get full text
Article -
160
Prostate Cancer Susceptibility Loci Identified in GATA2 and ZMIZ1 in Chinese Population
Published 2022-01-01“…Common genetic risk variants for prostate cancer (PCa) have been identified at approximately 170 loci using genome-wide association studies (GWAS), most of which were identified in European populations. …”
Get full text
Article